# Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)

> **NCT02454712** · PHASE1 · COMPLETED · sponsor: **Ensysce Biosciences** · enrollment: 64 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF614
- **DRUG:** Oxycodone extended-release
- **DRUG:** Naltrexone Hydrochloride

## Key facts

- **NCT ID:** NCT02454712
- **Lead sponsor:** Ensysce Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-16
- **Primary completion:** 2018-01-18
- **Final completion:** 2018-01-18
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02454712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02454712, "Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02454712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*